Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
0.9939
+0.0089 (0.90%)
May 8, 2025, 4:00 PM EDT - Market closed
Silexion Therapeutics Market Cap
Silexion Therapeutics has a market cap or net worth of $8.36 million as of May 8, 2025. Its market cap has decreased by -86.94% in one year.
Market Cap
8.36M
Enterprise Value
11.51M
1-Year Change
-86.94%
Ranking
Category
Stock Price
0.99
Market Cap Chart
Since April 7, 2021, Silexion Therapeutics's market cap has decreased from $148.55M to $8.36M, a decrease of -94.37%. That is a compound annual growth rate of -50.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2025 | 8.36M | 159.55% |
| Dec 31, 2024 | 3.22M | -92.33% |
| Dec 21, 2023 | 41.99M | -71.93% |
| Dec 30, 2022 | 149.59M | 4.03% |
| Dec 31, 2021 | 143.80M | -3.20% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 674.60B |
| Johnson & Johnson | 374.53B |
| UnitedHealth Group | 349.75B |
| AbbVie | 328.29B |
| Novo Nordisk | 287.72B |
| Abbott Laboratories | 233.14B |
| Novartis AG | 215.89B |
| AstraZeneca | 208.98B |